Onco-Innovations Limited
ONNVF
$2.65
$1.2285.32%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 46.00K | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 46.00K | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | 46.00K | -- | -- | -- | |
| SG&A Expenses | 2.04M | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 2.22M | -- | -- | -- | |
| Operating Income | -2.17M | -- | -- | -- | |
| Income Before Tax | -5.99M | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -5.99 | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -5.99M | -- | -- | -- | |
| EBIT | -2.17M | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | -0.18 | -- | -- | -- | |
| Normalized Basic EPS | -0.06 | -- | -- | -- | |
| EPS Diluted | -0.18 | -- | -- | -- | |
| Normalized Diluted EPS | -0.06 | -- | -- | -- | |
| Average Basic Shares Outstanding | 140.11M | -- | -- | -- | |
| Average Diluted Shares Outstanding | 140.11M | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |